questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Orphénadrine
Orphénadrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Douleur musculaire
Évaluation clinique
Imagerie médicale
Analyses sanguines
Spasmes musculaires
Indications thérapeutiques
Raideur musculaire
Symptômes cliniques
Fibromyalgie
Traitement de la douleur
Symptômes
5
Effets secondaires
Somnolence
Réactions allergiques
Éruptions cutanées
Troubles de la vision
Effets indésirables
Palpitations
Difficultés respiratoires
Prévention
5
Prévention des douleurs
Exercices physiques
Alimentation équilibrée
Santé musculaire
Stress
Tensions musculaires
Étirements
Flexibilité musculaire
Repos
Récupération musculaire
Traitements
5
Administration orale
Comprimés
Posologie
Traitement médicamenteux
Interactions médicamenteuses
Consultation médicale
Avantages thérapeutiques
Soulagement de la douleur
Douleurs chroniques
Efficacité thérapeutique
Complications
5
Complications
Troubles cardiaques
Dépendance
Utilisation prolongée
Complications graves
Convulsions
Gestion des complications
Ajustement du traitement
Fonction hépatique
Tests de laboratoire
Facteurs de risque
5
Facteurs de risque
Âge avancé
Personnes âgées
Sensibilité aux médicaments
Alcool
Efficacité médicamenteuse
Antécédents médicaux
Maladies cardiaques
Femmes enceintes
Précautions médicamenteuses
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Orphénadrine : Questions médicales les plus fréquentes",
"headline": "Orphénadrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Orphénadrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Orphénadrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques",
"url": "https://questionsmedicales.fr/mesh/D001559",
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "L S Sorokina",
"url": "https://questionsmedicales.fr/author/L%20S%20Sorokina",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D V Ryabova",
"url": "https://questionsmedicales.fr/author/D%20V%20Ryabova",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "A A Eremenko",
"url": "https://questionsmedicales.fr/author/A%20A%20Eremenko",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Shereen A Boltia",
"url": "https://questionsmedicales.fr/author/Shereen%20A%20Boltia",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
},
{
"@type": "Person",
"name": "Aya T Soudi",
"url": "https://questionsmedicales.fr/author/Aya%20T%20Soudi",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Modeling Low Muscle Mass Screening in Hemodialysis Patients.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36273447",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36179769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jamda.2022.08.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37169601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.breast.2023.05.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35971172",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-022-08394-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36057534",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.resinv.2022.07.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
},
{
"@type": "ListItem",
"position": 8,
"name": "Orphénadrine",
"item": "https://questionsmedicales.fr/mesh/D009966"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Orphénadrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Orphénadrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Orphénadrine",
"description": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?\nQuels tests sont utiles avant de prescrire l'orphénadrine ?\nL'orphénadrine est-elle indiquée pour tous les types de douleurs ?\nQuels signes cliniques justifient l'utilisation de l'orphénadrine ?\nL'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Orphénadrine",
"description": "Quels sont les effets secondaires courants de l'orphénadrine ?\nL'orphénadrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose d'orphénadrine ?\nL'orphénadrine peut-elle causer des troubles de la vision ?\nQuels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Orphénadrine",
"description": "Comment prévenir les douleurs nécessitant l'orphénadrine ?\nL'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?\nLe stress peut-il aggraver les douleurs musculaires ?\nDes étirements réguliers peuvent-ils prévenir les douleurs ?\nLe repos est-il important pour prévenir les douleurs musculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Orphénadrine",
"description": "Comment l'orphénadrine est-elle administrée ?\nQuelle est la posologie standard de l'orphénadrine ?\nL'orphénadrine peut-elle être combinée avec d'autres médicaments ?\nQuels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?\nL'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Orphénadrine",
"description": "Quelles complications peuvent survenir avec l'orphénadrine ?\nL'orphénadrine peut-elle entraîner une dépendance ?\nQuels signes indiquent une complication grave de l'orphénadrine ?\nComment gérer les complications liées à l'orphénadrine ?\nL'orphénadrine peut-elle affecter la fonction hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Orphénadrine",
"description": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?\nLes personnes âgées sont-elles plus sensibles à l'orphénadrine ?\nL'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?\nLes antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?\nLes femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Mass+Screening#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utiles avant de prescrire l'orphénadrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des analyses sanguines peuvent être réalisés pour évaluer l'état musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle indiquée pour tous les types de douleurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement indiquée pour les douleurs musculaires et les spasmes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques justifient l'utilisation de l'orphénadrine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs aiguës, des spasmes et une raideur musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée pour soulager certains symptômes de la fibromyalgie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de l'orphénadrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent la sécheresse buccale, la somnolence et des vertiges."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose d'orphénadrine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, hallucinations et tachycardie."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle causer des troubles de la vision ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une vision floue ou des troubles visuels temporaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des palpitations, des éruptions cutanées ou des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les douleurs nécessitant l'orphénadrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices réguliers, une bonne posture et des pauses fréquentes peuvent aider."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut contribuer à la santé musculaire."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les douleurs musculaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les tensions musculaires et les douleurs."
}
},
{
"@type": "Question",
"name": "Des étirements réguliers peuvent-ils prévenir les douleurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les étirements réguliers aident à maintenir la flexibilité et à prévenir les douleurs."
}
},
{
"@type": "Question",
"name": "Le repos est-il important pour prévenir les douleurs musculaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un repos adéquat est essentiel pour la récupération musculaire."
}
},
{
"@type": "Question",
"name": "Comment l'orphénadrine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'orphénadrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est de 100 mg deux fois par jour, selon les besoins."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle être combinée avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle offre un soulagement rapide des spasmes musculaires et des douleurs."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certaines douleurs chroniques, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'orphénadrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles cardiaques ou des problèmes neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle entraîner une dépendance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle a un faible potentiel de dépendance, mais une utilisation prolongée doit être surveillée."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave de l'orphénadrine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques, des évanouissements ou des convulsions."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'orphénadrine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin pour ajuster le traitement ou changer de médicament."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle affecter la fonction hépatique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests de la fonction hépatique peuvent être nécessaires en cas d'utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies préexistantes et l'utilisation d'autres médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus sensibles à l'orphénadrine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "L'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcool peut augmenter les effets sédatifs de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies cardiaques ou neurologiques peuvent limiter son utilisation."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'orphénadrine doit être utilisée avec prudence chez les femmes enceintes, après avis médical."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute for Nanotechnology and Water Sustainability, College of Science, Engineering and Technology, University of South Africa, Florida Science Campus, Roodepoort, 1710, South Africa.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria. christian.klampfl@jku.at.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Public health, Menofia University, Egypt.
Publications dans "Orphénadrine" :
Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based screening for such patients is challenging, espe...
Hemodialysis patients (n = 619) who had undergone abdominal CT screening were divided into the development (n = 441) and validation (n = 178) groups. PMI was manually measured using abdominal CT image...
Of all subjects, 226 (37%) were diagnosed with low muscle mass using PMI. A predictive model for low muscle mass was calculated using ten variables: each grip strength, sex, height, dry weight, primar...
Our results facilitate skeletal muscle screening in hemodialysis patients, assisting in sarcopenia prophylaxis and intervention decisions....
We aimed to examine the relationship between the fat-free mass index (FFMI; FFM/height...
Cross-sectional study....
This study included 1313 adults (women, 33.6%) aged 40-87 years (mean age, 55 ± 10 years) from the WASEDA'S Health Study....
Body composition was measured using multifrequency BIA and DXA. Low muscle mass was defined according to the criteria of the Asian Working Group for Sarcopenia 2019....
BIA-measured FFMI showed strong positive correlations with both BIA- (r = 0.96) and DXA-measured (r = 0.95) ASMIs. Similarly, in the subgroup analysis according to age and obesity, the FFMI was correl...
The FFMI showed a strong positive correlation with BIA- and DXA-measured ASMIs, regardless of age and obesity. The FFMI could be a useful simple surrogate marker of the ASMI for low muscle mass screen...
In Dutch breast cancer screening, solitary, new or growing well-circumscribed masses should be recalled for further assessment. This results in cancers detected but also in false positive recalls, esp...
A systematic literature search was performed using PubMed. In addition, follow-up data were retrieved on all 8860 recalled women in a Dutch screening region from 2014 to 2019....
Based on 15 articles identified in the literature search, we found that probably benign well-circumscribed masses that were kept under surveillance had a positive predictive value (PPV) of 0-2%. New o...
To recognize malignancies presenting as well-circumscribed masses, identifying solitary, new or growing lesions is key. This information is missing at initial screening since prior examinations are no...
Newborn screening (NBS) can prevent inborn errors of metabolism (IEMs), which may cause long-term disability and even death in newborns. However, in China, tandem mass spectrometry (MS/MS) screening h...
A Markov model was built to estimate the cost and quality-adjusted life-years (QALYs) of different screening programs. We compared PKU screening using traditional immunofluorescence (IF) with the othe...
The incremental cost-effectiveness ratio (ICER) of detecting all 12 IEMs in the national program is 277,823 RMB per QALY, below three times per capita GDP in Shenzhen. MS/MS screening in Shenzhen can ...
We conclude that the newborn screening using MS/MS in Shenzhen is cost-effective, and the budget affordable for the Shenzhen government. Two concepts for selecting the IEMs to be detected are also pre...
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, highlighting the need for efficient screening strategies to identify patients with COPD. However, there is little e...
In this cross-sectional study, we originally investigated the efficacy of mass screening for COPD among community residents in the aforementioned region using two COPD screening questionnaires....
From July 2018 through January 2019, 688 participants were enrolled. COPD was diagnosed using the Global Initiative for the Chronic Obstructive Lung Disease criteria. Twenty-one patients were newly di...
Mass screening for COPD using screening questionnaires, particularly the COPD-PS questionnaire, might be useful to identify the early stages of COPD in a medical health check-up population....
Although the study design for identifying specific disease associations using a health insurance database has been well-established, few studies explore unknown comorbidities. We conducted a series of...
Gastric cancer is an inflammation-related cancer triggered by Helicobacter pylori infection. Understanding of the natural disease course has prompted the hypothesis that gastric cancer can be prevente...
The early detection of symptoms and rapid testing are the basis of an efficient screening strategy to control COVID-19 transmission. The olfactory dysfunction is one of the most prevalent symptom and ...
The main goal of this study was to examine the relationship between exposure to mass media health campaign massages and the uptake of non-communicable diseases (NCDs) screening services in Ghana and w...
Updated data on the seroprevalences of hepatitis B and C viruses (HBV, HCV) are required to enable the adaptation of control strategies. In this study, we aimed to: (i) estimate the seroprevalences of...
From October 2020 to October 2022, a mass screening campaign was conducted in 10 cities across Burkina Faso. Individuals of all ages and genders who consented to participate were screened for viral ma...
A total of 15,650 participants were enrolled in the study. Of these, 51.4% were women and the age range was from 1 to 97 years. All participants were screened for HBsAg and 7,507 were also screened fo...
The prevalence of HBV and HCV infections remains high in Burkina Faso. Prevention strategies, including initial mass screening with rapid diagnostic tests and vaccination, need to be intensified....